Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FRUQUINTINIB vs FUTIBATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FRUQUINTINIB vs FUTIBATINIB: Safety Overview

Metric FRUQUINTINIB FUTIBATINIB
Total FAERS Reports 2,565 161
Deaths Reported 874 38
Death Rate 34.1% 23.6%
Hospitalizations 753 60
Average Patient Age 63.9 yrs 61.8 yrs
% Female Patients 44.4% 51.3%
FDA Approval Date Nov 8, 2023 Jul 28, 2025
Manufacturer Takeda Pharmaceuticals America, Inc. TAIHO PHARMACEUTICAL CO., LTD.
Route ORAL N/A
Marketing Status Prescription Prescription